Ernährung von Tumorpatienten

• Literatur

• 1 Dewys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491-497
• 2 Andreyev HJ, Norman AR, Oates J et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998; 34: 503-509
• 3 Ross PJ, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer 2004; 90: 1905-1911
• 4 Ravasco P, Monteiro-Grillo I, Vidal PM et al. Cancer: disease and nutrition are key determinants of patients quality of life. Support Care Cancer 2004; 12: 246-252
• 5 Good RA, West A, Day NK et al. Effects of undernutrition of host cell and organ function. Cancer Res 1982; 42 (Suppl. 02) 737s-746s
• 6 Skipworth RJE, Stewart GD, Dejong CHC et al. Pathophysiology of cancer cachexia: much more than host-tumour interaction?. Clin Nutr 2007; 26: 667-676
• 7 Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 2009; 7: 102
• 8 Arends J. Mangelernährung bei Tumorpatienten. Onkologe 2008; 14: 9-14
• 9 Evans WJ, Morley JE, Argilés J et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799
• 10 Shizgal HM. The effect of malnutrition on body composition. Surg Gynecol Obstet 1981; 152: 22-26
• 11 Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26: 1-22
• 12 Lundholm K, Holm G, Scherstén T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665-4670
• 13 Pajak B, Orzechowska S, Pijet B et al. Crossroads of cytokine signaling — the chase to stop muscle cachexia. J Physiol Pharmacol 2008; 59 (Suppl. 09) 251-264
• 14 Norman K, Stobäus N, Zocher D et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer (14.07.2010). Im Internet: http://www.ncbi.nlm.nih.gov/pubmed/20631202 Stand: 20.07.2010
• 15 Prado CMM, Baracos VE, McCargar LJ et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 2007; 13: 3264-3268
• 16 Prado CMM, Lieffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 7: 629-635
• 17 Dempsey DT, Feurer ID, Knox LS et al. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 1984; 53: 1265-1273
• 18 Arends J, Bodoky G, Bozzetti F et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr 2006; 2: 245-259
• 19 Kalm LM, Semba RD. They starved so that others be better fed: remembering Ancel Keys and the Minnesota experiment. J Nutr 2005; 135: 1347-1352
• 20 Kotler DP, Tierney AR, Culpepper-Morgan JA et al. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. J Parenter Enteral Nutr 1990; 14: 454-458
• 21 Bozzetti F, Arends J, Lundholm K et al. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 2009; 28: 445-454
• 22 Thibault R, Goujon N, Le Gallic E et al. Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk. Clin Nutr 2009; 28: 134-140
• 23 Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655
• 24 Jensen GL, Mirtallo J, Compher C et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. J Parenter Enteral Nutr 2010; 34: 156-159
• 25 Dulloo AG. Regulation of body composition during weight recovery: integrating the control of energy partitioning and thermogenesis. Clin Nutr 1997; 16 (Suppl. 01) 25-35
• 26 Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987; 27: 262-266
• 27 Holm E, Kämmerer U. Fette und Kohlenhydrate in Ernährungskonzepten für Tumorpatienten. Aktuel Ernahrungsmed 2011; 36: 286-298
• 28 Bruera E, Roca E, Cedaro L et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985; 69: 751-754
• 29 Maltoni M, Nanni O, Scarpi E et al. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 2001; 12: 289-300
• 30 Jatoi A, Windschitl HE, Loprinzi CL et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002; 20: 567-573
• 31 Lundholm K, Daneryd P, Bosaeus I et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 2004; 100: 1967-1977
• 32 Lundholm K, Daneryd P, Körner U et al. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 2004; 24: 505-512
• 33 Lundholm K, Gelin J, Hyltander A et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54: 5602-5606
• 34 Colomer R, Moreno-Nogueira JM, García-Luna PP et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007; 97: 823-831
• 35 van der Meij BS, Langius JAE, Smit EF et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 2010; 140: 1774-1780
• 36 Murphy RA, Mourtzakis M, Chu QSC et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 2011; 117: 1775-1782
• 37 Murphy RA, Mourtzakis M, Chu QSC et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011; 117: 3774-3780
• 38 Adachi S, Takiguchi S, Okada K et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010; 138: 1312-1320
• 39 Biesalski HK. Mikronährstoffsupplemente bei onkologischen Patienten: Gibt es rationale Gründe?. Aktuel Ernahrungsmed 2011; 36: 282-285
• 40 Arends J. Metabolism in cancer patients. Anticancer Res 2010; 30: 1863-1868
• 41 Na H-K, Oliynyk S. Effects of physical activity on cancer prevention. Ann N Y Acad Sci 2011; 1229: 176-183
• 42 Holmes MD, Chen WY, Feskanich D et al. Physical activity and survival after breast cancer diagnosis. J Am Med Assoc 2005; 293: 2479-2486
• 43 Meyerhardt JA, Giovannucci EL, Holmes MD et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006; 24: 3527-3534
• 44 Meyerhardt JA, Heseltine D, Niedzwiecki D et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006; 24: 3535-3541
• 45 McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. J Am Med Assoc 1994; 272: 1263-1266